Image

Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance

Study Investigating investigational medication in Patients with Advanced NSCLC and PDAC

Recruiting
18 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates metastatic or locally advanced non-small-cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC).

The study evaluates responses to an investigational medication in patients with these conditions, focusing on understanding how the body reacts to the treatment.

  • Who can participate: Adults aged 18 and older with metastatic or locally advanced NSCLC or PDAC, having a KRAS G12D mutation, may qualify. Participants should have undergone prior treatments and meet specific health criteria.
  • Study details: Participants will receive an investigational medication through a vein. Some may receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine.
Print
Study details
    Metastatic/Locally Advanced Non-Small-Cell Lung Cancer
    Metastatic/Locally Pancreatic Ductal Adenocarcinoma

NCT07483983

Gustave Roussy, Cancer Campus, Grand Paris

15 August 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.